Current Status

1
SELL
Current Status Current Trading Price 59.24
Current Holdings 40 shares G/L for purchase
price -1.6 Total loss to date (38.40) Key
Stats Market Cap 139.11B ROA 8.36 ROE
18.87 EPS 3.04
2

• Company Profile
• Swiss-based company with origins dating back to
  the eighteenth century
• Novartis AG engages in the research, development,
  manufacture, and sale of health care products
• Operates in four divisions Pharmaceuticals,
  Vaccines and Diagnostics, Sandoz, and Consumer
  Health

3
Versus the Drug Manufacturing Industry
4
Versus the SP 500
5
Owners Equity Model
6
Discounted Cash Flow
7
Gordons Growth Model
8
Technical Analysis
9
Current Events

• Diabetes Drug approval delay
• Competitors current Diabetes drug advantage
• Legal battle with Indian Government over patents
• Rumors of Nestle acquisition of Gerber

10
Recommendation

• SELL Current holdings
• Look into other Drug Manufacturers or companies
  in the Healthcare sector